Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TVP23B pseudogene 2 (TVP23BP2) is a non-functional genomic sequence that shares significant sequence homology with the protein-coding gene TVP23B, but does not produce a functional protein product. Pseudogenes such as TVP23BP2 generally arise from duplication or retrotransposition events and are incapable of encoding active proteins. Therefore, TVP23BP2 is not considered a therapeutic target and has no documented role in molecular classification, biological function, disease association, drug interaction, mechanism of drug action, biomarker status, or safety concern. For functional and therapy-relevant information, reference should be made to the protein-coding TVP23B gene, which encodes the trans-Golgi network vesicle protein 23 homolog B, a membrane protein involved in vesicle transport and intestinal homeostasis[2][3][5][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TVP23B pseudogene 2 (TVP23BP2).